Nasdaq
NDAQ
91.93
-0.34
-0.37%
Nasdaq
US · NDAQ
#430 by market cap
Listed 2005
91.93
-0.34
-0.37%
Live - 5344 symbols - heartbeat 193s ago
· 2026-10-08 08:38
Pre-market
91.92
-0.01%
After-hours
91.93
0.00%
Overnight
91.59
-0.37%
- Market cap
- 51.39B
- P/E (TTM)i
- 26.80
- P/Bi
- 4.29
- EPSi
- 3.09
- Div yieldi
- 1.22%
- 52W posi
- 64%
Reader sentiment
Are you bullish or bearish on NDAQ?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.60, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +11.65% YoY
Margins
- Gross margin
- 42.23%
- Operating margin
- 29.45%
- Net margin
- 21.64%
Key ratios & quality
- Enterprise valuei
- 57.04B
- PEG ratioi
- 1.60
- Altman Z-Scorei
- 2.60
PEG uses trailing P/E against the 3-year net income growth rate (16.70%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.28B | 4.26B | 5.63B | 5.89B | 6.23B | 6.06B | 7.40B | 8.26B |
| Gross profit | 1.66B | 1.66B | 1.94B | 2.23B | 2.34B | 2.55B | 2.99B | 3.49B |
| Selling & admin expenses | 396.00M | 388.00M | 425.00M | 395.00M | 420.00M | 417.00M | 427.00M | 424.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.05B | 1.09B | 1.32B | 1.56B | 1.66B | 1.81B | 1.95B | 2.43B |
| Pretax profit | 1.06B | 1.02B | 1.21B | 1.53B | 1.48B | 1.40B | 1.45B | 2.15B |
| Tax | 606.00M | 245.00M | 279.00M | 347.00M | 352.00M | 344.00M | 334.00M | 358.00M |
| Net profit | 458.00M | 774.00M | 933.00M | 1.19B | 1.12B | 1.06B | 1.12B | 1.79B |
| Basic EPS | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Diluted EPS | 0.91 | 1.54 | 1.86 | 2.35 | 2.26 | 2.08 | 1.93 | 3.09 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.10B | 2.10B | 1.96B | 2.12B | 2.14B | 2.53B |
| Gross profit | 816.00M | 861.00M | 870.00M | 942.00M | 958.00M | 1.02B |
| Selling & admin expenses | 84.00M | 106.00M | 105.00M | 130.00M | 121.00M | 124.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 576.00M | 597.00M | 607.00M | 651.00M | 672.00M | 731.00M |
| Pretax profit | 488.00M | 548.00M | 529.00M | 580.00M | 677.00M | 653.00M |
| Tax | 93.00M | 96.00M | 106.00M | 62.00M | 158.00M | 146.00M |
| Net profit | 395.00M | 452.00M | 423.00M | 518.00M | 519.00M | 507.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.68 | 0.78 | 0.73 | 0.90 | 0.91 | 0.89 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 6.37B | 4.29B | 7.66B | 7.42B | 8.60B | 9.10B | 7.79B | 8.00B |
| Cash & ST investments | 813.00M | 623.00M | 2.94B | 601.00M | 683.00M | 641.00M | 2.06B | 3.35B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 15.70B | 13.92B | 17.98B | 20.12B | 20.87B | 32.29B | 30.40B | 31.05B |
| Total current liabilities | 6.57B | 4.23B | 4.92B | 7.87B | 8.84B | 9.03B | 7.90B | 7.96B |
| Short-term debt | 875.00M | 391.00M | -- | 1.02B | 664.00M | 291.00M | 399.00M | 431.00M |
| Long-term debt | 2.96B | 3.00B | 5.54B | 4.81B | 4.74B | 10.16B | 9.08B | 8.57B |
| Total liabilities | 10,251,000,000.00 | 8,285,000,000.00 | 11,543,000,000.00 | 13,710,000,000.00 | 14,704,000,000.00 | 21,467,000,000.00 | 19,195,000,000.00 | 18,821,000,000.00 |
| Total equity | 5.45B | 5.64B | 6.44B | 6.41B | 6.16B | 10.83B | 11.20B | 12.23B |
| Retained earnings | 4.56B | 5.03B | 5.63B | 6.47B | 7.21B | 7.83B | 8.40B | 9.59B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 7.82B | 7.35B | 7.60B | 8.00B | 4.37B | 4.53B |
| Cash & ST investments | 2.55B | 2.01B | 2.53B | 3.35B | 2.38B | 2.79B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 30.65B | 30.38B | 30.65B | 31.05B | 27.30B | 27.34B |
| Total current liabilities | 7.97B | 7.66B | 7.71B | 7.96B | 4.39B | 4.51B |
| Short-term debt | 400.00M | 500.00M | 431.00M | 431.00M | 431.00M | 269.00M |
| Long-term debt | 8.93B | 8.68B | 8.67B | 8.57B | 8.53B | 8.49B |
| Total liabilities | 19,092,000,000.00 | 18,565,000,000.00 | 18,624,000,000.00 | 18,821,000,000.00 | 15,263,000,000.00 | 15,348,000,000.00 |
| Total equity | 11.56B | 11.82B | 12.03B | 12.23B | 12.04B | 11.99B |
| Retained earnings | 8.66B | 8.96B | 9.22B | 9.59B | 9.95B | 10.29B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.03B | 963.00M | 1.25B | 1.08B | 1.71B | 1.70B | 1.94B | 2.26B |
| Depreciation & amortization | 210.00M | 190.00M | 202.00M | 278.00M | 258.00M | 323.00M | 613.00M | 632.00M |
| Free cash flow | 917.00M | 836.00M | 1.06B | 920.00M | 1.55B | 1.54B | 1.73B | 1.99B |
| Dividends paid | -280.00M | -305.00M | -320.00M | -350.00M | -383.00M | -441.00M | -541.00M | -601.00M |
| Stock buybacks / issuance | -394.00M | -200.00M | -222.00M | -943.00M | -633.00M | -269.00M | -145.00M | -616.00M |
| Ending cash balance | 586.00M | 2.59B | 5.98B | 5.50B | 6.99B | 7.12B | 5.01B | 3.93B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 663.00M | 746.00M | 221.00M | 625.00M | 689.00M | 711.00M |
| Depreciation & amortization | 156.00M | 157.00M | 158.00M | 161.00M | 165.00M | 166.00M |
| Free cash flow | 614.00M | 687.00M | 152.00M | 536.00M | 629.00M | 634.00M |
| Dividends paid | -138.00M | -155.00M | -155.00M | -153.00M | -153.00M | -174.00M |
| Stock buybacks / issuance | -115.00M | -100.00M | -115.00M | -286.00M | -548.00M | -355.00M |
| Ending cash balance | 4.73B | 4.20B | 4.44B | 3.93B | 1.14B | 800.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 8.08 | 13.96 | 15.46 | 18.51 | 17.93 | 12.48 | 10.15 | 15.27 |
| ROA %i | 2.91 | 5.23 | 5.85 | 6.23 | 5.49 | 3.98 | 3.56 | 5.82 |
| ROIC %i | 5.71 | 9.16 | 9.39 | 9.81 | 9.84 | 6.99 | 6.56 | 9.59 |
| 5-year avg ROE %i | 7.46 | 8.87 | 10.46 | 13.78 | 14.79 | 15.67 | 14.91 | 14.87 |
| EBIT margin %i | 28.15 | 26.61 | 23.19 | 28.02 | 25.62 | 27.59 | 24.96 | 30.25 |
| FCF / sales %i | 21.44 | 19.62 | 18.91 | 15.63 | 24.96 | 25.36 | 23.41 | 24.07 |
| Current ratioi | 0.97 | 1.01 | 1.56 | 0.94 | 0.97 | 1.01 | 0.99 | 1.01 |
| Quick ratioi | 0.18 | 0.25 | 0.71 | 0.15 | 0.15 | 0.17 | 0.39 | 0.54 |
| Debt / assetsi | 24.40 | 26.70 | 32.98 | 30.90 | 28.04 | 33.66 | 32.47 | 30.48 |
| LT debt / equityi | 54.25 | 59.00 | 92.18 | 81.28 | 84.33 | 97.82 | 84.61 | 73.89 |
| Interest coveragei | 8.60 | 9.86 | 14.03 | 14.34 | 13.29 | 6.15 | 4.64 | 7.06 |
| Revenue CAGR (3Y) %i | 7.92 | 4.76 | 12.52 | 11.23 | 13.50 | 2.54 | 7.93 | 9.89 |
| Net income CAGR (3Y) %i | 2.28 | 94.00 | 8.57 | 37.36 | 13.28 | 4.31 | -2.01 | 16.70 |
| FCF CAGR (3Y) %i | 15.57 | 9.20 | 11.62 | 0.11 | 22.96 | 13.07 | 23.48 | 8.57 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.43 | 13.28 | 14.07 | 15.27 | 16.22 | 16.53 |
| ROA %i | 4.20 | 4.98 | 5.31 | 5.82 | 6.60 | 6.82 |
| ROIC %i | 7.33 | 8.41 | 8.81 | 9.59 | 10.14 | 10.38 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 25.74 | 27.28 | 29.02 | 30.25 | 32.28 | 31.77 |
| FCF / sales %i | 23.73 | 26.31 | 25.69 | 24.07 | 24.14 | 22.33 |
| Current ratioi | 0.98 | 0.96 | 0.99 | 1.01 | 1.00 | 1.01 |
| Quick ratioi | 0.44 | 0.38 | 0.44 | 0.54 | 0.77 | 0.88 |
| Debt / assetsi | 31.71 | 31.70 | 31.16 | 30.48 | 34.60 | 33.81 |
| LT debt / equityi | 80.71 | 77.31 | 75.86 | 73.89 | 74.91 | 74.86 |
| Interest coveragei | 5.20 | 5.81 | 6.48 | 7.06 | 7.75 | 8.28 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Market Services is the largest reported line at 54.19% of revenue, across 3 reported segments.
- Capital Access Platforms follows at 24.53%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Market Services54.19%
Capital Access Platforms24.53%
Financial technology21.29%
Quote time 2026-10-08 08:38:52 · For reference only, not investment advice and not tailored to your situation.